Sean D McGarry1, Sarah L Hurrell2, Kenneth Jacobsohn3, Kenneth A Iczkowski4, Michael Griffin2, Petar Duvnjak2, Andrew Nencka2, Mark Hohenwalter2, and Peter LaViolette2
1Biophysics, Medical College of Wisconsin, Wawautosa, WI, United States, 2Radiology, Medical College of Wisconsin, Wawautosa, WI, United States, 3Urologic Surgery, Medical College of Wisconsin, Wawautosa, WI, United States, 4Medical College of Wisconsin, Wawautosa, WI, United States
Synopsis
Prostate cancer is clinically defined by the
Gleason Score (GS), based on the pattern of cells and glands. While imaging is
useful for localizing prostate cancer, clinical diagnosis is based only on
pathology; as such, tools which combine clinical imaging and pathology are
highly useful as training tools. This study combines expert annotated histology
aligned with clinical imaging to provide a visualization tool, allowing the
user to select a region on the MRI and view the underlying pathology and
Gleason annotation.
Purpose
This study aimed to develop a software tool, which allows
the user to select a region on the MRI and view the underlying prostate cancer pathology
and tumor grade. Methods
39 Patients
underwent MP-MRI prior to prostatectomy on a 3T field strength MRI scanner
(General Electric, Waukesha, WI) using an endorectal coil. T2
acquisition parameters were: 3370 ms TR, 120 mm FOV, with voxel dimensions
0.23x0.23x3 mm, 512 acquisition matrix, and 26 slices. Two weeks after imaging
patients underwent a radical prostatectomy. A custom 3D printed slicing jig was
created from the T2 weighted image in order to slice the tissue in the same
orientation as the MRI[1-3]. Whole mount tissue samples were hematoxylin
and eosin stained, digitized, and sent to a urological pathologist for
annotation using the Gleason scale, including cribriform glands. Digitized slides were then aligned to the T2
weighted MRI using a non-linear control point warping technique. The pathologist
annotations were transformed into MRI space using the same transform.
The digitized histology was tiled into 1500x1500 pixel
squares. Each square was assigned an X and Y coordinate, creating an X and Y
coordinate map of histology tiles. The coordinate maps were subsequently
transformed into MRI space in order to link the histology tiles to their
corresponding locations in MRI space.
A user interface was generated in MATLAB allowing the user
to select a voxel on the MRI. The patient number, histology slide, and XY
coordinates from the previously generated coordinate map are used to load the
corresponding tiles underlying that location on the MRI. The tile is cropped
and a 400x400 tile is displayed. Additionally, because the expert annotation is
transformed into MRI space the user can view the Gleason grade of the
underlying pathology. Results and Discussion
The software functions as intended and displays the correct
underlying pathology. The tool functions on MRI slices and prostate regions where
tissue samples have been obtained and aligned. An example is shown in Figure 3,
where the user clicked on a region, and the underlying histology and tumor grade
is displayed. Clinical staging of prostate cancer based on imaging alone has a
high sensitivity of 85%, but a relatively low specificity at 55%[4]. The Rad-Path Surfer may aid clinical
decision making as a training tool by providing instant feedback regarding the
underlying pathology in naïve MRI data, allowing a clinician to better hone
their ability to recognize and classify cancer.Conclusion
This study developed a software tool, which allows the user
to view the true pathology causing an MRI signal. This may be useful as a
training tool for Radiologists.Acknowledgements
Advancing a Healthier Wisconsin and the State of Wisconsin Tax Check off
Program for Prostate Cancer Research. National Center for Advancing
Translational Sciences, NIH UL1TR001436 and
TL1TR001437, and RO1CA218144References
1. Hurrell SL, McGarry SD, Kaczmarowski AL, et al.
Optimized b-value selection for the discrimination of prostate cancer grades,
including the cribriform pattern, using diffusion weighted imaging. 2017.
2. LaViolette PS, Mickevicius NJ, Cochran EJ, et al.
Precise ex vivo histological validation of heightened cellularity and
diffusion-restricted necrosis in regions of dark apparent diffusion coefficient
in 7 cases of high-grade glioma. Neuro
Oncol. 2014;16(12):1599-1606.
3. Nguyen HS, Milbach N, Hurrell SL, et al.
Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with
Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival
in Patients with Recurrent Glioblastoma. AJNR
Am J Neuroradiol. 2016.
4. Muller BG, Shih JH, Sankineni S, et al. Prostate
Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging
Reporting and Data System at Multiparametric MR Imaging. Radiology. 2015;277(3):741-750.